Last update:
Oncology news
Scientists capture 'housekeeping' immune cells attacking live melanoma
Scientists at the Garvan Institute of Medical Research have captured, for the first time, "housekeeping" immune cells actively attacking and engulfing live melanoma cells—a discovery that could change the way we approach ...
13 hours ago
0
6
Decoding inflammatory bowel disease—on a chip
Inflammatory bowel disease (IBD), which comprises the inflammatory conditions Crohn's disease and ulcerative colitis, affects about 1.6 million Americans, many of whom cannot be effectively treated. This is mostly due to ...
15 hours ago
0
2
One‑week radiotherapy course shown to be safe and effective in the long term for early‑stage breast cancer
Research led by a Keele University oncologist has found that a one-week course of post-surgery radiotherapy is just as safe and effective as the traditional three-week course for people with early-stage breast cancer. The ...
12 hours ago
0
9
Data-driven biomaterials steer pancreatic cancer organoids into new cell states
Understanding and controlling how cancer cells transition between different states remains a critical challenge in tumor biology. In a recent publication in Advanced Materials, a team from the Leibniz Institute of Polymer ...
11 hours ago
0
2
Novel combination therapy could reduce leukemia relapse rate, extending window for bone marrow transplants
A research team from the Department of Medicine, School of Clinical Medicine, LKS Faculty of Medicine, the University of Hong Kong (HKUMed), has developed a novel combination therapy that significantly improves treatment ...
12 hours ago
0
2
Researcher develops 'smart, tiny bubbles' to treat cancer and heart disease
A cell 500 times thinner than a human hair could heal hearts and kill cancer cells, thanks to a patent-pending technology created by a University of Central Florida researcher and now licensed to a university donor in hopes ...
8 hours ago
0
3
Gut bacteria linked to immunotherapy success in melanoma patients
Researchers at The George Washington University, working with Weill Cornell Medicine, have identified specific gut bacteria linked to better responses to cancer immunotherapy in patients with advanced melanoma. The study ...
13 hours ago
0
2
Elite immune cells lead the fight against multiple myeloma
Immunotherapy for cancer works like a guided missile, directing the body's immune cells toward tumor cells. However, not all immune cells respond to the call to attack, and this can lead to variability in treatment responses. ...
9 hours ago
0
1
Targeting inflammation may help overcome drug resistance in colon cancer
Chemotherapy drugs that target a common mutation in colorectal cancer rapidly lose efficacy in patients, leading to relapse. According to a new preclinical study by Weill Cornell Medicine and MD Anderson Cancer Center investigators, ...
18 hours ago
0
3
New marker identifies patients with advanced prostate cancer more likely to benefit from combination immunotherapy
Researchers with the James P. Allison Institute at The University of Texas MD Anderson Cancer Center have discovered a new gene expression signature within tumors that can help identify patients with metastatic castration-resistant ...
20 hours ago
0
5
Study sheds light on how early pancreas lesions become cancerous
In an unexpected finding, a new study flips on its head researchers' understanding of how precancerous pancreas lesions evolve into pancreatic cancer. The paradigm-changing discovery has tremendous implications for identifying ...
19 hours ago
0
3
Clinical trial tests virus-immunotherapy combination for neuroendocrine tumors
A Phase I clinical trial is testing whether a tumor-targeting virus can help immunotherapy work more effectively against aggressive neuroendocrine tumors that often resist treatment. Researchers at Sylvester Comprehensive ...
12 hours ago
0
3
Dermatologists and oncologists call for overhaul of widely used cancer side-effect grading system
Physicians at the Icahn School of Medicine at Mount Sinai are calling for updates to a widely used system that grades side effects from cancer treatments, warning that current criteria may misclassify the severity of skin-related ...
13 hours ago
0
2
Oral drug proves highly effective against chemotherapy-related low platelets in GI cancer trial
An oral medication already approved for thrombocytopenia in patients with liver disease significantly improved platelet recovery and helped patients with gastrointestinal cancers maintain platelet counts needed to continue ...
12 hours ago
0
1
Breast cancer drug is effective for treatment-resistant uterine cancer
Uterine cancer is the deadliest cancer of the female reproductive system. Currently, clinicians treat the disease by using a mix of surgery and chemotherapy. But not everyone responds to this line of treatment, and those ...
17 hours ago
0
4
Study targets alcohol marketing that downplays breast cancer risk
Memorial Day weekend, the unofficial start of summer, is a peak holiday for alcohol consumption, with nearly half of celebrants reporting they plan to buy alcoholic beverages. Public health experts are raising concern that ...
18 hours ago
0
3
Implantable tech could cast new light on bladder cancer treatment
A new implantable device which aims to maximize the effectiveness of light-sensitive drugs could improve outcomes for bladder cancer patients in the future. Engineers and cancer scientists from the University of Glasgow are ...
15 hours ago
0
1
Adding a lower cutoff value for CA19-9 may identify additional high-risk cases of pancreatic cancer
A dual-threshold model for measuring the pancreatic tumor marker serum carbohydrate antigen 19-9 (CA19-9) identified patients with pancreatic cancer who had high-risk disease despite having low CA19-9 levels because of a ...
May 21, 2026
0
4
Cracking the code of p53 fragility: Why the genome guardian is prone to failure
The protein p53 is often called the guardian of the genome for its central role in preventing cancer. Yet paradoxically, it is also one of the most frequently mutated and dysfunctional proteins in human tumors.
May 20, 2026
2
9
Saliva could flag one of the deadliest and most baffling cancers sooner
Scientists at the Sydney Brenner Institute for Molecular Bioscience (SBIMB) at Wits University are exploring whether bacteria in saliva could offer a low-cost warning signal for esophageal squamous cell carcinoma, where late ...
May 20, 2026
0
11
Cytokine-armored CAR-T cell therapy helps eliminate aggressive brain tumors in preclinical study
Scientists at the UCLA Health Jonsson Comprehensive Cancer Center have developed a new cytokine-armored CAR-T cell therapy that helps the immune system better attack aggressive brain tumors in mice while reducing dangerous ...
May 20, 2026
0
7
How dead tumor cells could make chemotherapy and radiotherapy work better
As tumors outgrow their blood and nutrient supplies, or respond to treatments like chemotherapy and radiotherapy, individual cancer cells die, exposing their internal scaffolds. These dead cells are an abundant source of ...
May 20, 2026
0
7
Researchers identify new drug targets for hard-to-treat cancers
Despite impressive innovations in medicine, most advanced-stage cancers still carry a grim prognosis. Developing more effective treatments requires a deeper understanding of the cellular processes that drive the formation ...
May 20, 2026
0
6
Early warning from low-risk cysts could help catch pancreatic cancer sooner
Catching pancreatic cancer early can increase the five-year survival rate from 15% to 80%. Patients with pancreatic cysts, frequently detected during unrelated abdominal CT or MRI imaging, can develop malignant pancreatic ...
May 20, 2026
0
6
